After more than three decades working in global healthcare and biopharmaceutical leadership, I’ve had the privilege of helping organizations expand across international markets, launch innovative therapies, and build high-performing teams. I’m grateful for the experiences that have shaped my journey and for the opportunity to contribute to the advancement of healthcare worldwide. Here is my biography.

Ross Bundy is a pioneering biotechnology leader driving innovation in biosensor technology and genome editing optimization. As the CEO of CRISPR QC and co-founder of Cardea Bio Inc., he has been instrumental in developing platforms that enable real-time biological insights through the "Internet of Biology." With expertise in business development, financial strategy, and operational management, Bundy has successfully scaled multiple companies and forged key industry partnerships. His visionary leadership and strategic execution continue to shape the future of biotechnology, advancing diagnostics, therapeutics, and bioinformatics with cutting-edge solutions.